nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—Imatinib—hematologic cancer	0.645	1	CrCtD
Buclizine—Imatinib—Nilotinib—hematologic cancer	0.282	0.815	CrCrCtD
Buclizine—Meclizine—Imatinib—hematologic cancer	0.0641	0.185	CrCrCtD
Buclizine—Imatinib—ABL2—hematologic cancer	0.000454	0.18	CrCbGaD
Buclizine—Imatinib—LCK—hematologic cancer	0.000433	0.172	CrCbGaD
Buclizine—Imatinib—CSF1R—hematologic cancer	0.000261	0.103	CrCbGaD
Buclizine—Imatinib—PDGFRB—hematologic cancer	0.000228	0.0902	CrCbGaD
Buclizine—Imatinib—PDGFRA—hematologic cancer	0.000222	0.0879	CrCbGaD
Buclizine—Imatinib—ABL1—hematologic cancer	0.000203	0.0804	CrCbGaD
Buclizine—Imatinib—KIT—hematologic cancer	0.000163	0.0645	CrCbGaD
Buclizine—Imatinib—CA9—hematologic cancer	0.000156	0.062	CrCbGaD
Buclizine—Imatinib—SLC22A1—hematologic cancer	0.000129	0.0511	CrCbGaD
Buclizine—Imatinib—ABCG2—hematologic cancer	9.02e-05	0.0357	CrCbGaD
Buclizine—Fexofenadine—ABCB1—hematologic cancer	4.3e-05	0.0171	CrCbGaD
Buclizine—Imatinib—ALB—hematologic cancer	3.93e-05	0.0156	CrCbGaD
Buclizine—Imatinib—ABCB1—hematologic cancer	3.75e-05	0.0149	CrCbGaD
Buclizine—Azelastine—ABCB1—hematologic cancer	3.64e-05	0.0144	CrCbGaD
Buclizine—Loperamide—ABCB1—hematologic cancer	2.74e-05	0.0109	CrCbGaD
Buclizine—CHRM1—GPCR downstream signaling—PRKCG—hematologic cancer	4.1e-06	0.000592	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—RAC2—hematologic cancer	4.09e-06	0.00059	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DKK1—hematologic cancer	4.07e-06	0.000588	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DKK1—hematologic cancer	4.06e-06	0.000586	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT5B—hematologic cancer	4.04e-06	0.000583	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT5B—hematologic cancer	4.03e-06	0.000581	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ADCY7—hematologic cancer	3.92e-06	0.000566	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ADCY7—hematologic cancer	3.91e-06	0.000564	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CSF2—hematologic cancer	3.87e-06	0.000558	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CSF2—hematologic cancer	3.85e-06	0.000557	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	3.84e-06	0.000554	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—IL2RA—hematologic cancer	3.83e-06	0.000553	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—XIAP—hematologic cancer	3.81e-06	0.000551	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—XIAP—hematologic cancer	3.8e-06	0.000549	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	3.73e-06	0.000539	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—JAK1—hematologic cancer	3.73e-06	0.000539	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PRKCG—hematologic cancer	3.72e-06	0.000537	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—JAK1—hematologic cancer	3.72e-06	0.000537	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	3.72e-06	0.000537	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SH2B3—hematologic cancer	3.72e-06	0.000537	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SH2B3—hematologic cancer	3.7e-06	0.000535	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SMARCA4—hematologic cancer	3.7e-06	0.000535	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GZMB—hematologic cancer	3.69e-06	0.000533	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GZMB—hematologic cancer	3.68e-06	0.000532	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	3.61e-06	0.000521	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CTNNA1—hematologic cancer	3.59e-06	0.000519	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	3.59e-06	0.000518	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL3—hematologic cancer	3.59e-06	0.000518	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HSPB1—hematologic cancer	3.59e-06	0.000518	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HSPB1—hematologic cancer	3.57e-06	0.000516	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL3—hematologic cancer	3.57e-06	0.000516	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EIF4EBP1—hematologic cancer	3.57e-06	0.000516	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTHLH—hematologic cancer	3.55e-06	0.000512	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SDC1—hematologic cancer	3.55e-06	0.000512	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SDC1—hematologic cancer	3.53e-06	0.00051	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTHLH—hematologic cancer	3.53e-06	0.00051	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	3.49e-06	0.000503	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL2RA—hematologic cancer	3.47e-06	0.000502	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTGER4—hematologic cancer	3.45e-06	0.000498	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTGER4—hematologic cancer	3.44e-06	0.000497	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LCK—hematologic cancer	3.43e-06	0.000496	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LCK—hematologic cancer	3.42e-06	0.000494	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—H3F3A—hematologic cancer	3.37e-06	0.000486	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—H3F3A—hematologic cancer	3.35e-06	0.000484	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	3.27e-06	0.000472	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKCZ—hematologic cancer	3.26e-06	0.000471	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	3.2e-06	0.000462	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CG—hematologic cancer	3.19e-06	0.00046	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PARP1—hematologic cancer	3.16e-06	0.000456	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PARP1—hematologic cancer	3.15e-06	0.000455	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FBXW7—hematologic cancer	3.11e-06	0.000449	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FBXW7—hematologic cancer	3.1e-06	0.000447	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CXCR4—hematologic cancer	3.05e-06	0.00044	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HDAC2—hematologic cancer	3.05e-06	0.00044	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HDAC2—hematologic cancer	3.04e-06	0.000439	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CXCR4—hematologic cancer	3.04e-06	0.000439	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CBL—hematologic cancer	2.97e-06	0.000429	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CBL—hematologic cancer	2.96e-06	0.000428	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL3—hematologic cancer	2.94e-06	0.000424	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL3—hematologic cancer	2.93e-06	0.000423	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	2.9e-06	0.000419	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CG—hematologic cancer	2.89e-06	0.000418	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTPN1—hematologic cancer	2.89e-06	0.000417	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTPN1—hematologic cancer	2.88e-06	0.000416	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	2.85e-06	0.000412	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PTPN11—hematologic cancer	2.84e-06	0.000411	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	2.84e-06	0.000411	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	2.83e-06	0.000409	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SYK—hematologic cancer	2.83e-06	0.000409	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—RASGRP1—hematologic cancer	2.83e-06	0.000409	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HSP90AA1—hematologic cancer	2.83e-06	0.000408	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SYK—hematologic cancer	2.83e-06	0.000408	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	2.81e-06	0.000406	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	2.8e-06	0.000405	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	2.76e-06	0.000399	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CREB1—hematologic cancer	2.76e-06	0.000398	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT1—hematologic cancer	2.73e-06	0.000395	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT1—hematologic cancer	2.72e-06	0.000393	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	2.7e-06	0.000391	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	2.7e-06	0.000389	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCL2—hematologic cancer	2.7e-06	0.000389	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL6R—hematologic cancer	2.69e-06	0.000388	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	2.65e-06	0.000383	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	2.65e-06	0.000382	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	2.58e-06	0.000373	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—JAK2—hematologic cancer	2.57e-06	0.000371	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	2.57e-06	0.000371	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—MAP2K1—hematologic cancer	2.56e-06	0.00037	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GRB2—hematologic cancer	2.56e-06	0.000369	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	2.55e-06	0.000369	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	2.55e-06	0.000368	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GRB2—hematologic cancer	2.55e-06	0.000368	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CD—hematologic cancer	2.54e-06	0.000367	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFA—hematologic cancer	2.54e-06	0.000367	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KITLG—hematologic cancer	2.51e-06	0.000363	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KITLG—hematologic cancer	2.51e-06	0.000362	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	2.46e-06	0.000355	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	2.45e-06	0.000354	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT5A—hematologic cancer	2.45e-06	0.000354	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	2.44e-06	0.000353	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	2.44e-06	0.000352	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CDKN2B—hematologic cancer	2.43e-06	0.000351	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	2.41e-06	0.000348	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3R1—hematologic cancer	2.4e-06	0.000347	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CD86—hematologic cancer	2.36e-06	0.00034	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CD86—hematologic cancer	2.35e-06	0.000339	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	2.34e-06	0.000338	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—JAK2—hematologic cancer	2.34e-06	0.000337	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HES1—hematologic cancer	2.32e-06	0.000336	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HES1—hematologic cancer	2.32e-06	0.000334	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	2.31e-06	0.000334	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	2.3e-06	0.000333	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGF1—hematologic cancer	2.28e-06	0.00033	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CSF2—hematologic cancer	2.28e-06	0.00033	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGF1—hematologic cancer	2.28e-06	0.000329	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CSF2—hematologic cancer	2.28e-06	0.000329	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	2.25e-06	0.000325	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	2.25e-06	0.000325	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	2.25e-06	0.000325	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	2.24e-06	0.000324	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	2.24e-06	0.000324	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	2.24e-06	0.000323	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	2.23e-06	0.000321	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	2.22e-06	0.00032	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	2.21e-06	0.000319	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	2.21e-06	0.000318	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—JAK1—hematologic cancer	2.21e-06	0.000318	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	2.21e-06	0.000318	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—JAK1—hematologic cancer	2.2e-06	0.000317	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	2.2e-06	0.000317	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	2.06e-06	0.000297	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	2.05e-06	0.000296	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL2—hematologic cancer	2.04e-06	0.000295	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL2—hematologic cancer	2.04e-06	0.000294	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TERT—hematologic cancer	2.04e-06	0.000294	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TERT—hematologic cancer	2.03e-06	0.000293	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	1.99e-06	0.000287	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	1.98e-06	0.000286	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TSC2—hematologic cancer	1.94e-06	0.00028	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	1.94e-06	0.00028	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	1.87e-06	0.00027	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	1.86e-06	0.000269	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	1.85e-06	0.000267	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	1.84e-06	0.000266	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ESR1—hematologic cancer	1.81e-06	0.000262	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	1.81e-06	0.000261	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FN1—hematologic cancer	1.79e-06	0.000259	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FN1—hematologic cancer	1.79e-06	0.000258	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—BAD—hematologic cancer	1.77e-06	0.000256	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	1.77e-06	0.000256	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—BAD—hematologic cancer	1.77e-06	0.000255	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	1.77e-06	0.000255	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	1.75e-06	0.000253	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	1.75e-06	0.000253	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CD80—hematologic cancer	1.72e-06	0.000248	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	1.72e-06	0.000248	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KIT—hematologic cancer	1.72e-06	0.000248	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	1.72e-06	0.000248	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CD80—hematologic cancer	1.71e-06	0.000247	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	1.71e-06	0.000247	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KIT—hematologic cancer	1.71e-06	0.000247	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	1.71e-06	0.000247	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	1.69e-06	0.000243	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	1.68e-06	0.000243	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	1.64e-06	0.000237	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	1.64e-06	0.000236	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CREB1—hematologic cancer	1.63e-06	0.000236	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	1.63e-06	0.000235	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—BRAF—hematologic cancer	1.61e-06	0.000233	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	1.61e-06	0.000232	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL2—hematologic cancer	1.6e-06	0.000231	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL6R—hematologic cancer	1.59e-06	0.00023	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	1.59e-06	0.00023	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	1.59e-06	0.00023	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	1.59e-06	0.000229	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	1.59e-06	0.000229	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	1.52e-06	0.000219	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	1.51e-06	0.000219	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	1.51e-06	0.000218	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	1.5e-06	0.000217	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.49e-06	0.000216	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.49e-06	0.000215	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	1.48e-06	0.000213	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	1.47e-06	0.000213	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—FGF2—hematologic cancer	1.44e-06	0.000209	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	1.44e-06	0.000208	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	1.42e-06	0.000206	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	1.42e-06	0.000205	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—JAK2—hematologic cancer	1.38e-06	0.0002	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	1.38e-06	0.000199	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	1.36e-06	0.000196	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.35e-06	0.000195	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MDM2—hematologic cancer	1.35e-06	0.000195	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	1.35e-06	0.000194	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MTOR—hematologic cancer	1.31e-06	0.00019	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	1.31e-06	0.00019	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	1.31e-06	0.000189	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.31e-06	0.000189	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	1.26e-06	0.000181	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	1.25e-06	0.000181	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	1.23e-06	0.000178	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.23e-06	0.000178	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	1.22e-06	0.000176	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.22e-06	0.000176	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CASP3—hematologic cancer	1.21e-06	0.000175	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL2—hematologic cancer	1.21e-06	0.000174	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	1.21e-06	0.000174	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL2—hematologic cancer	1.2e-06	0.000174	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.2e-06	0.000173	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	1.2e-06	0.000173	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCND1—hematologic cancer	1.18e-06	0.00017	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—JUN—hematologic cancer	1.17e-06	0.00017	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	1.17e-06	0.000169	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—JUN—hematologic cancer	1.17e-06	0.000169	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.14e-06	0.000164	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.14e-06	0.000164	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.13e-06	0.000164	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.13e-06	0.000163	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.11e-06	0.00016	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.11e-06	0.00016	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.11e-06	0.00016	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.1e-06	0.00016	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.08e-06	0.000156	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.08e-06	0.000156	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.05e-06	0.000152	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.05e-06	0.000152	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.03e-06	0.000148	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.02e-06	0.000148	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.02e-06	0.000147	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.01e-06	0.000146	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.01e-06	0.000146	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.01e-06	0.000146	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	9.71e-07	0.00014	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	9.67e-07	0.00014	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MYC—hematologic cancer	9.44e-07	0.000136	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	9.42e-07	0.000136	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MYC—hematologic cancer	9.41e-07	0.000136	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	9.39e-07	0.000136	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KRAS—hematologic cancer	8.72e-07	0.000126	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	8.69e-07	0.000126	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	8.01e-07	0.000116	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	7.99e-07	0.000115	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TP53—hematologic cancer	7.75e-07	0.000112	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TP53—hematologic cancer	7.73e-07	0.000112	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HRAS—hematologic cancer	7.41e-07	0.000107	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	7.39e-07	0.000107	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL6—hematologic cancer	7.1e-07	0.000102	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL6—hematologic cancer	7.07e-07	0.000102	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AKT1—hematologic cancer	6.55e-07	9.45e-05	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	6.53e-07	9.42e-05	CbGpPWpGaD
